Deepika Bodapati – Co-Founder of Athelas – Remote Healthcare Monitoring In Mental Health

Deepika Bodapati is the co-founder of Athelas, a company working with patients living with Treatment-Resistant Schizophrenia (TRS) to overcome the challenges of constant lab work when prescribed clozapine.

The Athelas One is an FDA-cleared blood diagnostics device that helps simplify and enhance the blood monitoring process for those prescribed clozapine and other immunosuppressed patients. This system eliminates the need for a venous draw, with an  onsite finger-prick that returns neutrophil and white blood cell count within minutes.